# Chase Williams

> Chase Williams is a Series B investor at Goldman Sachs Growth Equity backing Health Care and SaaS. See 3 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Goldman Sachs Growth Equity](https://shizune.co/investors/profile/gs-growth)
- Location: New York, United States
- Total investments: 3
- Last investment: Feb 2025
- Lead investor: 67%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/chase-williams-70344b34

Chase Williams is a Series B investor at Goldman Sachs Growth Equity in New York focused on Health Care and SaaS. Chase Williams is the Growth Equity Investor at Goldman Sachs. Chase Williams attended Colgate University.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 2 | 67% |
| SaaS | 1 | 33% |
| Medical | 1 | 33% |
| mHealth | 1 | 33% |
| Software | 1 | 33% |

9 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series B | 2 | 67% |
| Series C | 1 | 33% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Fay | Fay is helping people eat better, and live better by connecting them with dietitians covered by their health insurance. | $50M | Series B | Feb 04, 2025 |  |
| H1.co | H1 is an AI-powered platform that helps identify and engage the right doctors for critical workflows across pharma, health plan, health system, and technology companies. At the core of the platform is H1’s Doctor Graph—a structured representation of physician identity, expertise, relationships, and behavioral signals, creating a powerful networkeffect as it is continuously enriched by participants across the healthcare ecosystem. Built on one of the world’s largest and most comprehensive global datasets of healthcare professionals, H1 combines deep healthcare data with agentic AI workflows to power critical workflows across drug development, medical and commercial engagement, care navigation, and provider data and network intelligence. Founded in 2017, the company is based in New York, United States. | $23M | Series C | Jun 09, 2022 |  |
| eVisit | Evisit is a web application that connects primary care providers with their patients by webcam or phone for the remote diagnosis and treatment of most minor medical conditions. The company is changing the healthcare delivery model and disrupting the $135 billion dollars primary care market by allowing physicians to recapture patient visits from theUrgent Care and Emergency Room. Physicians reclaim lost revenue from missed appointments, and patients receive high-quality care from work, home, or on the road from the doctor that knows them best.The eVisit platform allows providers to collect patient co-pays, electronically prescribe prescriptions to the pharmacy of the patients' choice, and submit medical charts for reimbursement to 3rd party payers. Unlike other telemedicine companies, eVisit circumvents many of the regulatory issues by maintaining the doctor-patient relationship and keeping patients in their PCMH (Patient-Centered Medical Home). | $45M | Series B | Sep 21, 2021 |  |

3 of 3 investments shown.

## Co-investors
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund, 2 deals together
- [Menlo Ventures](https://shizune.co/investors/profile/menlo-ventures) — VC Fund, 2 deals together
- [Bray Capital](https://shizune.co/investors/profile/bray-capital) — VC Fund, 1 deal together
- [Forerunner](https://shizune.co/investors/profile/forerunner-ventures) — VC Fund, 1 deal together
- [Frazier VC](https://shizune.co/investors/profile/fraziervc) — VC Fund, 1 deal together
- [Novartis Pharma](https://shizune.co/investors/profile/novartis-pharma) — VC Fund, 1 deal together

## About Goldman Sachs Growth Equity

VC Fund · New York, United States

As part of the Merchant Banking Division of Goldman Sachs, GS Growth is the firm’s investment platform dedicated to providing preferred equity and mezzanine capital to high-growth companies.As of June 2019, Goldman Sachs' investing groups (Goldman Sachs Growth Equity, Principal Strategic Investments, and Private Capital Investing) havecombined to form the GS Growth team. The team targets investments of $20-250 million.

5 contacts available at Goldman Sachs Growth Equity.

| Name | Title | Profile |
| --- | --- | --- |
| Ashwin Gupta | Managing Director | https://shizune.co/investors/profile/ashwin-gupta |
| Cassidy Blonsky | Owner | https://shizune.co/investors/profile/cassidy-blonsky-986c |
| Chase Williams | Growth Equity Investor | https://shizune.co/investors/profile/chase-williams-0479 |
| Kirk A. Lepke | Vice President | https://shizune.co/investors/profile/kirk-lepke |
| Kirk A. Lepke | Vice President | https://shizune.co/investors/profile/kirk-a-lepke |

## Similar investors

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

## FAQ

### What does Chase Williams invest in?

Chase Williams invests primarily in Health Care, SaaS and Medical startups, most often at Series B and Series C stage. Most of the 3 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Chase Williams last invest?

The most recent investment recorded for Chase Williams closed in Feb 2025. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co